ARACYTINE 100 mg, powder and solvent for solution for injection bottle, 5 ml
Active ingredients: Cytarabine
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for solution for injectionbottle, 5 mlintrathécale;intraveineuse;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ARACYTINE 100 mg, poudre et solvant pour solution injectable
- Pharmaceutical form
- poudre et solvant pour solution injectable
- Route of administration
- intrathécale;intraveineuse;sous-cutanée
- Presentation description
- 1 flacon(s) en verre de 100 mg de poudre - 1 ampoule(s) en verre de 5 ml de solvant
- Marketing authorisation holder
- PFIZER HOLDING FRANCE
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Mar 1972
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61517592CIP73026721CIP133400930267219Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CYTARABINEpoudre | 100,00 mg · un flacon de 100 mg de poudre | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.